S9912 Combination Chemo in Stage III Ovarian Cancer,
Status:
Completed
Trial end date:
2008-02-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy work in different ways to stop tumor cells from
dividing so they stop growing or die. Combining more than one drug may kill more tumor cells.
PURPOSE: Phase II trial to study the effectiveness of combining paclitaxel, cisplatin, and
liposomal doxorubicin in treating women who have undergone surgery for stage III ovarian
cancer, fallopian tube cancer, or primary peritoneal cancer.